Products — Brontec inyectable

Brontec inyectable



  • Rapid bronchodilator action.
  • Dilates clogged bronchi and fluidizes and removes viscous mucus, rapidly increasing pulmonary ventilation.
  • Eliminates dyspnea and normalizes breathing.
  • Prevents the release of Histamine.
  • Decreases the formation of inflammation mediators.
  • Increased secretory activity due to increased ciliary movement.


Specific bronchodilator for horses, based on Clenbuterol.


Clenbuterol 0,03 mg/ml


For the treatment of respiratory infections and bronchial obstructions that present with mucus accumulation and/or bronchospasm with acute and chronic conditions in horses: Cough and dyspnea due to bronchial spasm, COPD, Bronchitis, Bronchopneumonia.

It is suggested to start the treatment by administering Brontec Inyectable, then continue to administer Brontec Gel or Brontec Plus at the recommended doses.

Therapeutic Action:

Bronchodilator action: it acts at the level of the beta receptors of the bronchial muscles, solving the reversible bronchospasm, increasing the air passage and normalizing breathing.

Expectorant action: increases secretomotor activity (ciliary movement), by increasing cellular energy metabolism promoting the elimination of mucus.

Antiallergic action: prevents the release of histamine by stabilizing the cell membrane of mast cells.

Anti-inflammatory action: inhibits the formation of inflammation mediators (Prostaglandins and Leukotrins), helping to control inflammatory symptoms.

Dosage and Administration:

Brontec should be administered at a dose of 0,8 μg Clenbuterol per kg b.w. twice daily.

Brontec Inyectable: Apply slow IM or IV, 2,5 ml Every 100 kg b.w. Twice a day. Inhalation 2 ml twice a day.

After an obvious improvement, the volume or the number of dose per day can be reduced. The duration of treatment depends on a considerable number of factors related to the disease, etiology, duration of the process, etc. that the treating practitioner will evaluate appropriately. In acute and subacute cases the treatment will be maintained for 10 to 14 days. In chronic processes it will be treated for at least 4 weeks until the total absence of symptoms is reached. In patients hypersensitive to environmental allergens, treatment can be administered discontinuously.




Vial of 50 ml.